Terms: = Prostate cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A AND Staging
6 results:
1. [THE EVOLUTION OF MARKERS OF prostate cancer].
Peshkov MN; Generozov EV; Kostryukova ES
Klin Lab Diagn; 2016 Mar; 61(3):132-40. PubMed ID: 27506103
[TBL] [Abstract] [Full Text] [Related]
2. Quality of life in T1-3N0 prostate cancer patients treated with radiation therapy with minimum 10-year follow-up.
Johnstone PA; Gray C; Powell CR
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):833-8. PubMed ID: 10705003
[TBL] [Abstract] [Full Text] [Related]
3. Second primary malignancies in T1-3N0 prostate cancer patients treated with radiation therapy with 10-year followup.
Johnstone PA; Powell CR; Riffenburgh R; Rohde DC; Kane CJ
J Urol; 1998 Mar; 159(3):946-9. PubMed ID: 9474189
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic impact of transurethral resection on patients irradiated for localized prostate cancer.
Arcangeli G; Micheli A; Verna L; Saracino B; Arcangeli G; Giovinazzo G; D'Angelo L; Pansadoro V; Sternberg CN
Radiother Oncol; 1995 May; 35(2):123-8. PubMed ID: 7569020
[TBL] [Abstract] [Full Text] [Related]
5. Are three substages of clinical B prostate carcinoma useful in predicting disease-free survival?
Glick AJ; Philput CB; el Mahdi A; Ladaga L; Schellhammer PF
Urology; 1990 Dec; 36(6):483-7. PubMed ID: 2247912
[TBL] [Abstract] [Full Text] [Related]
6. Radiotherapy of prostate carcinoma: results of treatment and complications.
Sack H; Nosbuesch H; Stuetzer H
Radiother Oncol; 1987 Sep; 10(1):7-15. PubMed ID: 3671775
[TBL] [Abstract] [Full Text] [Related]
